MEDIFAST shares are trading lower after DA Davidson downgraded the stock from Neutral to Underperform and lowered its price target from $25 to $17.5.
Portfolio Pulse from Benzinga Newsdesk
MEDIFAST shares are trading lower after DA Davidson downgraded the stock from Neutral to Underperform and lowered its price target from $25 to $17.5.
June 05, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
DA Davidson downgraded MEDIFAST from Neutral to Underperform and reduced its price target from $25 to $17.5, causing the stock to trade lower.
The downgrade from DA Davidson and the significant reduction in the price target are likely to negatively impact investor sentiment and lead to a short-term decline in MEDIFAST's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100